[1] YANG F, CHEN Y, LU Z, et al. Treatment of knee osteoarthritis with acupuncture combined with Chinese herbal medicine: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(11):11430-11444.
[2] LAMO-ESPINOSA JM, PRÓSPER F, BLANCO JF, et al. Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis. J Transl Med. 2021;19(1):506.
[3] 王新军,袁银鹏,王越,等.软骨细胞凋亡引发骨关节炎的机制研究进展[J].山东医药,2020,60(2):109-112.
[4] 吴昊,黄震,李磊.LncRNA ZFAS1影响骨关节炎软骨细胞增殖和凋亡的机制研究[J].局解手术学杂志,2022,31(12):1039-1045.
[5] 白冰,孙铭霞,孙彦豹,等.脂肪源性干细胞在小鼠膝关节骨关节炎中的作用研究[J].河北医学,2022,28(10):1659-1663.
[6] KLOSE-JENSEN R, HARTLEV LB, BOEL LWT, et al. Subchondral bone turnover, but not bone volume, is increased in early stage osteoarthritic lesions in the human hip joint. Osteoarthritis Cartilage. 2015;23(12):2167-2173.
[7] YOUNG DA, BARTER MJ, SOUL J. Osteoarthritis year in review: genetics, genomics, epigenetics. Osteoarthritis Cartilage. 2022;30(2):216-225.
[8] ROBINSON WH, LEPUS CM, WANG Q, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580-592.
[9] 杨本雷.中国彝族药学[M].昆明:云南民族出版社,2004.
[10] 郑梅梅,郑俭彬,江自鲜,等.两种斯赤列提取物促进成骨细胞的增殖与分化[J].中国组织工程研究,2023,27(11):1677-1682.
[11] CHEN YF, JOBANPUTRA P, BARTON P, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2008;12(11):1-278, iii.
[12] PÉREZ-LOZANO ML, CESARO A, MAZOR M, et al. Emerging Natural-Product-Based Treatments for the Management of Osteoarthritis. Antioxidants (Basel). 2021;10(2):265.
[13] 刘冬丽,王葳,陈飞龙,等.血满草化学成分及生物活性的研究进展[J].华西药学杂志,2018,33(6):542-545.
[14] 武海波,赵奕宁,李冬梅,等.血满草化学成分研究[J].天然产物研究与开发,2013,25(3):345-348.
[15] 张森,张娜,杨增明,等.云南习用药材血满草的质量标准研究[J].云南中医学院学报,2008,31(1):17-21.
[16] KAMEKURA S, HOSHI K, SHIMOAKA T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage. 2005;13(7):632-641.
[17] CRISOL M, WU K, LAOUAR L, et al. Antioxidant additives reduce reactive oxygen species production in articular cartilage during exposure to cryoprotective agents. Cryobiology. 2020;96:114-121.
[18] BOLDUC JA, COLLINS JA, LOESER RF. Reactive oxygen species, aging and articular cartilage homeostasis. Free Radic Biol Med. 2019;132:73-82.
[19] PHILLIPS R. PGE2 receptor antagonist has potential to treat osteoarthritis. Nat Rev Rheumatol. 2022;18(5):245.
[20] TU M, YANG M, YU N, et al. Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis. Bone Res. 2019; 7:29.
[21] JIANG W, JIN Y, ZHANG S, et al. PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis. Bone Res. 2022;10(1):27.
[22] FAN T, CHEN S, ZENG M, et al. Osteophytes mediate the associations between cartilage morphology and changes in knee symptoms in patients with knee osteoarthritis. Arthritis Res Ther. 2022;24(1):217.
[23] MADRY H, VAN DIJK CN, MUELLER-GERBL M. The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):419-433.
[24] 鲍哲明,单青,李晨,等.碘乙酸钠大鼠骨关节炎模型骨微结构研究[J].中国骨质疏松杂志,2022,28(2):210-214,219.
[25] ZAMLI Z, ROBSON BROWN K, TARLTON JF, et al. Subchondral bone plate thickening precedes chondrocyte apoptosis and cartilage degradation in spontaneous animal models of osteoarthritis. Biomed Res Int. 2014; 2014:606870.
[26] BAY-JENSEN AC, HOEGH-MADSEN S, DAM E, et al. Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis? Rheumatol Int. 2010;30(4):435-442.
[27] INTEMA F, HAZEWINKEL HA, GOUWENS D, et al. In early OA, thinning of the subchondral plate is directly related to cartilage damage: results from a canine ACLT-meniscectomy model. Osteoarthritis Cartilage. 2010;18(5): 691-698.
[28] 曹峻岭.蛋白聚糖与软骨结构、功能及骨关节病的关系[J].西安交通大学学报(医学版) ,2012,33(2):131-136.
[29] NAGEEN B, SARFRAZ I, RASUL A, et al. Eupatilin: a natural pharmacologically active flavone compound with its wide range applications. J Asian Nat Prod Res. 2020;22(1):1-16.
[30] FEI J, LIANG B, JIANG C, et al. Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model. Biomed Pharmacother. 2019;109:1586-1592.
[31] WANG C, GAO Y, ZHANG Z, et al. Ursolic acid protects chondrocytes, exhibits anti-inflammatory properties via regulation of the NF-κB/NLRP3 inflammasome pathway and ameliorates osteoarthritis. Biomed Pharmacother. 2020;130:110568.
[32] ZHAO R, DONG Z, WEI X, et al. Inflammatory factors are crucial for the pathogenesis of post-traumatic osteoarthritis confirmed by a novel porcine model: “Idealized” anterior cruciate ligament reconstruction” and gait analysis. Int Immunopharmacol. 2021;99:107905.
[33] ZHAO X, WANG T, CAI B, et al. MicroRNA-495 enhances chondrocyte apoptosis, senescence and promotes the progression of osteoarthritis by targeting AKT1. Am J Transl Res. 2019;11(4):2232-2244.
[34] 倪佳,徐莹莹,邓婉玲,等.人MAPK3基因克隆及其在肝细胞癌细胞中的作用[J].遵义医科大学学报,2022,45(4):463-469.
[35] TAO T, LUO D, GAO C, et al. Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Promotes Inflammation and Accelerates Osteoarthritis by Activating β-Catenin. Front Cell Dev Biol. 2021;9:646386.
[36] JIA H, MA X, TONG W, et al. EGFR signaling is critical for maintaining the superficial layer of articular cartilage and preventing osteoarthritis initiation. Proc Natl Acad Sci U S A. 2016;113(50):14360-14365.
[37] ZHANG X, ZHU J, LIU F, et al. Reduced EGFR signaling enhances cartilage destruction in a mouse osteoarthritis model. Bone Res. 2014;2:14015.
[38] GUI T, WEI Y, LUO L, et al. Activating EGFR Signaling Attenuates Osteoarthritis Development Following Loading Injury in Mice. J Bone Miner Res. 2022;37(12):2498-2511.
[39] WEI Y, MA X, SUN H, et al. EGFR Signaling Is Required for Maintaining Adult Cartilage Homeostasis and Attenuating Osteoarthritis Progression. J Bone Miner Res. 2022;37(5):1012-1023.
[40] WEI Y, LUO L, GUI T, et al. Targeting cartilage EGFR pathway for osteoarthritis treatment. Sci Transl Med. 2021;13(576):eabb3946.
[41] HUDSON BI, LIPPMAN ME. Targeting RAGE Signaling in Inflammatory Disease. Annu Rev Med. 2018;69:349-364.
[42] 姜婷,滕士超,安晓飞,等.中医药干预AGEs-RAGE信号通路改善糖尿病肾病的机制研究概述[J].环球中医药,2022,15(1):173-178.
|